Revolution Medicines (RVMD) Shares Outstanding (2018 - 2026)

Revolution Medicines' Shares Outstanding history runs 9 years deep, the most recent figure standing at $200.2 million for Q1 2026.

• In Q1 2026, Shares Outstanding rose 7.47% year-over-year to $200.2 million; the TTM figure through Mar 2026 stood at $200.2 million (up 7.47% YoY), while the FY2025 annual figure was $197.0 million, up 5.97% from the prior year.
• Shares Outstanding was $200.2 million for Q1 2026 at Revolution Medicines, up from $197.0 million in the prior quarter.
• In the past five years, Shares Outstanding ranged from a high of $200.2 million in Q1 2026 to a low of $2.0 million in Q1 2023.
• Historically, Shares Outstanding has averaged $144.7 million across 5 years, with a median of $164.9 million in 2024.
• The sharpest annual moves came in 2023 and 2024: Shares Outstanding slumped 97.24% in 2023, then soared 7962.42% in 2024.
• A 5-year view of Shares Outstanding shows it stood at $90.4 million in 2022, then jumped by 82.14% to $164.7 million in 2023, then gained by 12.89% to $185.9 million in 2024, then advanced by 5.97% to $197.0 million in 2025, then advanced by 1.61% to $200.2 million in 2026.
• The last three Shares Outstanding figures came in at $200.2 million (Q1 2026), $197.0 million (Q4 2025), and $189.7 million (Q3 2025), per Business Quant data.